welcome
Yahoo Finance

Yahoo Finance

Health

Health

Eli Lilly reports mixed earnings, increases 2025 guidance

Yahoo Finance
Summary
Nutrition label

88% Informative

Eli Lilly ( LLY ) reported fourth quarter and full year earnings for 2024 Thursday .

Results largely beat Wall Street estimates and sent its stock up about 2% in pre-market trading.

But the company missed on GLP-1 sales, with sales of Mounjaro for diabetes and Zepbound for weight loss.

For the full year , Lilly reported $45 billion in revenue.

VR Score

91

Informative language

90

Neutral language

85

Article tone

formal

Language

English

Language complexity

43

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links